Trinity Bio ADR (TRIB) Stock Price, Quote & News

Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mump...

Industry: Medical Devices

Sector: Healthcare

Phone: 353 1 276 9800

Fax: 353 1 276 9888

Website: www.trinitybiotech.com

Address:

IDA Business Park, Bray, Ireland

deepthinker Jul. 4 at 4:01 PM

$TRIB Still wondering about Jeon, especially now with getting into data centers. He’s never let go of his holdings. He’d have to deal with Perceptive.

0 · Reply

Clydagh Jul. 3 at 5:48 PM

$TRIB Tuesday July 7 is our new target date. and please don't ask "for what?"

3 · Reply

Super5Investments Jul. 2 at 4:40 PM

$TRIB only reason its up a few pennies today is because those in automatic investments with the old DRIP plan go through today

0 · Reply

RipVolta Jul. 2 at 4:13 PM

$TRIB

0 · Reply

NasdaqAlpha Jul. 2 at 3:41 PM

$TRIB new clinical trial data is a solid read-through for CGM+. Over 5,000 hours of wear data suggests Trinity’s tech is aimed at a real pain point for CGM users — not just glucose, but going beyond glucose-only monitoring. If validated, that’s a meaningful product angle.

0 · Reply

MarketExplorerr Jul. 2 at 3:39 PM

$TRIB just posted clinical data on its CGM+ wearable platform showing it can separate false overnight glucose alarms from real hypoglycemia. That’s a real issue in CGM use, and if this holds up, it could meaningfully improve trust in the readings and reduce alarm fatigue. Early but a notable step for the next-gen platform.

0 · Reply

MajorGainz7 Jul. 2 at 2:19 PM

$TRIB .40s break imminent

0 · Reply

SniperMaster00 Jul. 2 at 2:19 PM

$TRIB let’s have a day!!! 🇺🇸👊👊

0 · Reply

kd1313 Jul. 2 at 1:48 PM

$TRIB probably close down with good news.

0 · Reply

Clydagh Jul. 2 at 1:35 PM

$TRIB the best news today

0 · Reply

New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring

Jun 30, 2026, 9:00 AM EDT - 4 days ago

Trinity Biotech's Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling

2026-06-29T19:20:10.000Z - 5 days ago

Trinity Biotech terminates standby equity purchase agreement with Yorkville

Jun 29, 2026, 3:15 PM EDT - 5 days ago

Trinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville

Jun 23, 2026, 7:30 AM EDT - 11 days ago

Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market

Jun 18, 2026, 4:00 PM EDT - 16 days ago

Trinity Biotech Earnings release: Q1 2026

2026-06-16T13:30:59.000Z - 18 days ago

Trinity Biotech receives purchase orders for 2M units of TrinScreen HIV

Jun 16, 2026, 9:10 AM EDT - 18 days ago

Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results

Jun 3, 2026, 8:00 AM EDT - 4 weeks ago

Trinity Biotech Registration statement: Registration filing

2026-05-13T20:46:47.000Z - 7 weeks ago

Trinity Biotech files to sell 167.95M American depositary shares

May 13, 2026, 8:00 AM EDT - 7 weeks ago

Trinity Biotech Registration statement: Registration filing

May 13, 2026, 8:00 AM EDT - 7 weeks ago

Trinity Biotech Registration statement: Registration filing

May 1, 2026, 9:27 AM EDT - 2 months ago

Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations

Apr 30, 2026, 7:00 AM EDT - 2 months ago

Trinity Biotech Annual report: Q4 2025

Apr 30, 2026, 7:00 AM EDT - 2 months ago

Trinity Biotech Slides: Q4 2025

Mar 23, 2026, 9:23 AM EDT - 3 months ago

Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test

2026-03-18T12:36:02.000Z - 3 months ago

Trinity Biotech announes collaboration agreement with University at Buffalo

Mar 18, 2026, 8:30 AM EDT - 3 months ago

Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren's Syndrome

2026-03-12T13:09:29.000Z - 4 months ago

Trinity Biotech begins rollout of glucose monitoring system in Brazil

Mar 12, 2026, 9:00 AM EDT - 4 months ago

Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System

Mar 11, 2026, 9:00 AM EDT - 4 months ago

Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program

2026-03-10T12:01:30.000Z - 4 months ago

Trinity Biotech announces advancements in CGM system development

2026-03-10T11:56:35.000Z - 4 months ago

Trinity Biotech says continuing to focus on Comprehensive Transformation Plan

Mar 10, 2026, 7:55 AM EDT - 4 months ago

Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform

2026-03-10T11:50:13.000Z - 4 months ago

Trinity Biotech sees Q4 revenue $11.5M-$12.5M vs. $15.9M last year

Mar 10, 2026, 7:45 AM EDT - 4 months ago

Trinity Biotech Provides Business and Trading Update

2026-02-25T14:17:27.000Z - 4 months ago

Trinity Biotech files to sell 35.28M American Depositary Shares for holders

2026-02-25T14:14:32.000Z - 4 months ago

Trinity Biotech secures $25M standby equity purchase agreement

Feb 25, 2026, 9:00 AM EST - 4 months ago

Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives

Feb 25, 2026, 7:00 AM EST - 4 months ago

Trinity Biotech Registration statement: Registration filing

2026-02-20T22:10:49.000Z - 4 months ago

Trinity Biotech receives noncompliance notification from Nasdaq

Feb 20, 2026, 5:00 PM EST - 4 months ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

2026-02-13T22:10:18.000Z - 5 months ago

Trinity Biotech receives noncompliance notification from Nasdaq

Feb 13, 2026, 5:00 PM EST - 5 months ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement

2026-02-10T18:35:27.000Z - 5 months ago

Trinity secures regulatory approval for upstream manufacturing activities

Feb 10, 2026, 1:28 PM EST - 5 months ago

Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation

2026-02-10T13:27:39.000Z - 5 months ago

Trinity achieves IFCC Gold Classification for Premier Hb9210 HbA1c Analyser

Feb 10, 2026, 8:00 AM EST - 5 months ago

Trinity Biotech Glucose Monitoring Innovation Achieves Unique Global Recognition: Diabetes Care Premier Hb9210™ HbA1c Analyser Becomes the Only System Awarded Prestigious IFCC Gold Classification for 2026

2026-01-15T21:35:23.000Z - 6 months ago

Trinity Biotech files to sell 55.89M American depositary shares

Dec 23, 2025, 9:30 AM EST - 6 months ago

Trinity Biotech Slides: Q3 2025

2025-12-23T13:55:09.000Z - 6 months ago

Trinity Biotech enters series of agreements with Perceptive Advisors funds

Dec 23, 2025, 8:50 AM EST - 6 months ago

Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives

Dec 23, 2025, 8:30 AM EST - 6 months ago

Trinity Biotech Slides: Q2 2025

2025-12-23T12:41:04.000Z - 6 months ago

Trinity Biotech reports Q3 revenue $14.3 vs. $10.8M last quarter

2025-12-23T12:40:56.000Z - 6 months ago

Trinity Biotech continues to make ‘substantial progress’ on Transformation Plan

2025-12-23T12:40:47.000Z - 6 months ago

Trinity Biotech ‘committed to pursuing immediate growth opportunities’

2025-12-23T12:40:40.000Z - 6 months ago

Trinity Biotech appoints Paul Murphy as interim CFO

Dec 23, 2025, 7:32 AM EST - 6 months ago

Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests

Dec 15, 2025, 9:15 AM EST - 7 months ago

Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances

Nov 18, 2025, 9:00 AM EST - 8 months ago

Trinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation

Nov 14, 2025, 9:00 AM EST - 8 months ago

Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test

Oct 27, 2025, 9:00 AM EDT - 8 months ago

Trinity Biotech Welcomes Perceptive Advisor's Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting Growth

Sep 2, 2025, 9:30 AM EDT - 10 months ago

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

Aug 21, 2025, 9:00 AM EDT - 11 months ago

Trinity Biotech Appoints Paul Tivnan as Non-Executive Director

Aug 20, 2025, 9:00 AM EDT - 11 months ago

Regulatory Approval Granted for Commencement of Trinity Biotech's Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation

Aug 14, 2025, 9:00 AM EDT - 11 months ago

Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara™ Preeclampsia Testing Service

Aug 12, 2025, 8:45 AM EDT - 11 months ago

Trinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM Sensor

Aug 7, 2025, 8:00 AM EDT - 11 months ago

Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service

Jul 24, 2025, 8:20 AM EDT - 1 year ago

Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market

Jul 1, 2025, 9:00 AM EDT - 1 year ago

Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround

Jul 1, 2025, 7:00 AM EDT - 1 year ago

Trinity Biotech Slides: Q1 2025

Jun 24, 2025, 8:00 AM EDT - 1 year ago

Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation

May 16, 2025, 6:00 AM EDT - 1 year ago

Trinity Biotech Earnings release: Q4 2024

May 16, 2025, 6:00 AM EDT - 1 year ago

Trinity Biotech Annual report: Q4 2024

May 15, 2025, 4:00 PM EDT - 1 year ago

Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update

Mar 21, 2025, 8:00 AM EDT - 1 year ago

Trinity Biotech Registration statement: Registration Filing

Mar 14, 2025, 4:30 PM EDT - 1 year ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement

Mar 13, 2025, 7:30 AM EDT - 1 year ago

Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process

Feb 28, 2025, 8:30 AM EST - 1 year ago

Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring Technology

Feb 6, 2025, 7:30 AM EST - 1 year ago

Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial

Jan 28, 2025, 7:20 AM EST - 1 year ago

Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology

Dec 24, 2024, 8:33 AM EST - 1 year ago

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

Dec 18, 2024, 11:00 AM EST - 1 year ago

Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV

Nov 29, 2024, 7:00 AM EST - 1 year ago

Trinity Biotech Registration statement: Registration Filing

Nov 15, 2024, 10:00 AM EST - 1 year ago

Trinity Biotech Earnings Call Transcript: Q3 2024

Nov 15, 2024, 10:00 AM EST - 1 year ago

Trinity Biotech Earnings release: Q3 2024

Nov 15, 2024, 9:00 AM EST - 1 year ago

Trinity Biotech Announces Q3 2024 Financial Results

Nov 15, 2024, 7:00 AM EST - 1 year ago

Trinity Biotech Registration statement: Registration Filing

Nov 14, 2024, 8:07 AM EST - 1 year ago

Trinity Biotech to Announce Q3 2024 Financial Results

Oct 25, 2024, 8:45 AM EDT - 1 year ago

Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

Oct 25, 2024, 8:45 AM EDT - 1 year ago

Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

Oct 7, 2024, 8:15 AM EDT - 1 year ago

Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology

Sep 24, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

Sep 18, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

Sep 9, 2024, 4:05 PM EDT - 1 year ago

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

Sep 3, 2024, 9:55 AM EDT - 1 year ago

Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer

Aug 26, 2024, 4:05 PM EDT - 2 years ago

Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales

deepthinker Jul. 4 at 4:01 PM

$TRIB Still wondering about Jeon, especially now with getting into data centers. He’s never let go of his holdings. He’d have to deal with Perceptive.

0 · Reply

Clydagh Jul. 3 at 5:48 PM

$TRIB Tuesday July 7 is our new target date. and please don't ask "for what?"

3 · Reply

Super5Investments Jul. 2 at 4:40 PM

$TRIB only reason its up a few pennies today is because those in automatic investments with the old DRIP plan go through today

0 · Reply

RipVolta Jul. 2 at 4:13 PM

$TRIB

0 · Reply

NasdaqAlpha Jul. 2 at 3:41 PM

0 · Reply

MarketExplorerr Jul. 2 at 3:39 PM

0 · Reply

MajorGainz7 Jul. 2 at 2:19 PM

$TRIB .40s break imminent

0 · Reply

SniperMaster00 Jul. 2 at 2:19 PM

$TRIB let’s have a day!!! 🇺🇸👊👊

0 · Reply

kd1313 Jul. 2 at 1:48 PM

$TRIB probably close down with good news.

0 · Reply

Clydagh Jul. 2 at 1:35 PM

$TRIB the best news today

0 · Reply

MajorGainz7 Jul. 2 at 12:52 PM

$TRIB back to .40+

0 · Reply

ChicDaBears Jul. 1 at 6:55 PM

$PFSA $OSRH $TRIB LFGGGG @TCLutz 🤑💎🤑💎🤑💎🤑💎

0 · Reply

ChicDaBears Jul. 1 at 6:37 PM

$OSRH added this AND added $TRIB 🤑🔥💎🤑🔥💎🤑🔥💎

0 · Reply

TCLutz Jul. 1 at 4:20 PM

$TRIB 🫡💪🔥

1 · Reply

TCLutz Jul. 1 at 3:31 PM

$TRIB Adding. 🫡💪🔥

0 · Reply

Think_Bigly Jul. 1 at 3:31 PM

$TRIB WTF up. Bloom Energy Rises On Big AI Infrastructure Expansion Updated 09:42 AM ET 07/01/2026 Bloom Energy announced a big AI infrastructure deal expansion. Shares rose Wednesday, but off overnight highs. Late Tuesday, Bloom Energy (BE) announced a massive expansion of its alliance with Brookfield Asset Management (BAM) to finance power ‌projects for AI data centers. The new partnership is for $25 billion, up fivefold from the $5 billion announced last October.

0 · Reply

Think_Bigly Jul. 1 at 3:22 PM

$TRIB Liquid Cooling for Data Centers - IPO with former Google CFO as CEO. What would 20M shares of that go off at: Likely $8 Legacy biz sold to ABT, or Bayer. That's what this is.

0 · Reply

SniperMaster00 Jul. 1 at 3:07 PM

$TRIB holding 45k shares average .36! I’ll add more if dips! Easy $1 soon! $TC $DXF

1 · Reply

SabbyManagementLLC Jun. 30 at 10:46 PM

$TRIB

1 · Reply

RipVolta Jun. 30 at 7:24 PM

$TRIB Okay I’m in 🙃

1 · Reply

Jmiz1986 Jun. 30 at 5:45 PM

$TRIB I’ve seen a few posts about this today. Can I get a some context about this ? I see some ai news this morning but not so clear what the catalyst is.

0 · Reply

KevinohWarsh Jun. 30 at 5:44 PM

$TRIB yep I was looking at the same thing. You see a huge candle come through doesn’t even move it small sells are dropping it??

0 · Reply

Market Cap	1.35M
Revenue (ttm)	43.79M
Net Income (ttm)	-37.38M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-85.36%
Debt to Equity Ratio	-1.50

Volume	1,004,100
Avg Vol	1,564,696
Day's Range	N/A - N/A
Shares Out	3.59M
Stochastic %K	22%
Beta	N/A
Analysts	Strong Buy
Price Target	$15.00